ZAGNI, Irene
 Distribuzione geografica
Continente #
NA - Nord America 930
EU - Europa 664
AS - Asia 341
SA - Sud America 5
OC - Oceania 2
Totale 1.942
Nazione #
US - Stati Uniti d'America 927
GB - Regno Unito 228
CN - Cina 222
SG - Singapore 111
SE - Svezia 78
IE - Irlanda 77
FR - Francia 67
DE - Germania 60
RU - Federazione Russa 58
FI - Finlandia 40
IT - Italia 30
UA - Ucraina 15
BR - Brasile 4
CA - Canada 3
RO - Romania 3
AT - Austria 2
BE - Belgio 2
IN - India 2
NL - Olanda 2
TR - Turchia 2
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PS - Palestinian Territory 1
Totale 1.942
Città #
Southend 197
Chandler 184
Jacksonville 182
Woodbridge 95
Singapore 90
Houston 80
Dublin 77
Ashburn 61
Ann Arbor 49
Nanjing 30
Wilmington 29
Jinan 27
New York 27
Lawrence 23
Princeton 23
Shenyang 23
Kent 22
Lancaster 20
Sindelfingen 18
Helsinki 15
Haikou 13
Hebei 13
Tianjin 12
Beijing 9
Nanchang 9
Rome 9
Boardman 8
Hangzhou 8
Milan 7
Changsha 6
Jiaxing 6
Ningbo 6
Taiyuan 6
Taizhou 6
Verona 6
Zhengzhou 5
Falls Church 4
Lanzhou 4
Caltanissetta 3
Guangzhou 3
Leawood 3
Moscow 3
Nürnberg 3
Qingdao 3
San Mateo 3
Seattle 3
Auburn Hills 2
Bangalore 2
Brussels 2
Chicago 2
Dallas 2
Edinburgh 2
Falkenstein 2
Ficarazzi 2
Norwalk 2
San Diego 2
Timisoara 2
Toronto 2
Washington 2
Ardabil 1
Auckland 1
Augusta 1
Brasília 1
Canberra 1
Canoas 1
Fairfield 1
Frankfurt am Main 1
Gangdong-gu 1
Mehlingen 1
Monmouth Junction 1
Oklahoma City 1
Ottawa 1
Provo 1
Redwood City 1
Ribeirão Preto 1
San Francisco 1
Santa Clara 1
Sofia 1
São Paulo 1
Tokyo 1
Vienna 1
Warsaw 1
Totale 1.482
Nome #
Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis. 146
Hepatitis C virus genotype and prognosis of compensated cirrhosis type C 102
Effect of hepatitis B and C virus infection on the natural history of compensated cirrhosis: a cohort study of 297 patients. 94
Consensus interferon (CIFN) in combination with ribavirin (RBV) for naive patients with chronic hepatitis C: a multicenter study 93
A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone. 93
Influence of hepatitis delta virus infection on clinical outcome of compensated cirrhosis type B 92
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C. 87
Hepatocellularcarcinoma in cirrhosis: incidence and risk factors. 86
Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C. 85
Natural course and prognostic factors of hepatitis B. 82
Efficacy of prolonged high dose of interferon (IFN) plus ribavirin in young genotype 1/4 patients with chronic hepatitis C not responding to IFN alone 82
Incidenza e fattori di rischio di epatocarcinoma. 80
Natural history of hepatitis B virus infection and disease 79
Natural history of hepatitis B and prognostic factors of disease progression 79
Efficacy and safety of consensus interferon (CIFN) plus ribavirin (RBV) for naive patients with chronic hepatitis C (CHC): final report of a pilot study 79
Final report of a consensus interferon (CIFN) plus ribavirin (RBV) study for chronic hepatitis C (CHC) 78
Interferon (IFN) induction followed by prolonged high dose IFN in combination with ribavirin (RBV) for relapsers HCV patients: a randomized controlled multicenter trial 78
Antifibrogenic effect of combination interferon plus ribavirin treatment in patients with chronic hepatitis C 77
Hepatocellular carcinoma in cirrhosis:incidence and risk factors 74
Storia naturale della epatite cronica e cirrosi da virus C. 72
The risk of hepatocellular carcinoma (HCC) among patients with cirrhosis 72
Efficacy of consensus interferon (CIFN) plus ribavirin (RBV) as initial treatment for chronic hepatitis C patients: an italian multicentre study 68
The risk of hepatocellular carcinoma (HCC) in cirrhosis 66
Totale 1.944
Categoria #
all - tutte 6.202
article - articoli 2.065
book - libri 0
conference - conferenze 3.089
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.048
Totale 12.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020146 0 0 0 0 1 18 24 23 7 26 6 41
2020/2021214 14 42 35 15 15 19 0 23 15 0 33 3
2021/2022163 10 43 1 3 26 5 2 10 11 3 8 41
2022/2023448 33 64 40 92 32 98 7 23 42 3 9 5
2023/2024220 8 12 19 44 39 39 4 2 0 2 36 15
2024/2025200 20 36 2 107 35 0 0 0 0 0 0 0
Totale 1.944